- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: cMET positive NSCLC
Total 14719 results
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
PfizerActive, not recruitingCarcinoma, Non-Small-Cell LungCanada, Spain, United States, China, Korea, Republic of, United Kingdom, France, Czechia, Japan, Singapore, Taiwan, Australia, Netherlands, India, Turkey, Hong Kong, Argentina, Belgium, Germany, Italy, Mexico, Poland, Russian Federation
-
European Organisation for Research and Treatment...Active, not recruitingNon Small Cell Lung CancerNetherlands, Spain, France, United Kingdom, Norway, Jordan, Belgium
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
-
Novartis PharmaceuticalsAvailable
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
OSE ImmunotherapeuticsTerminatedNon Small Cell Lung CancerFrance, Spain, Israel, United States, United Kingdom, Italy, Poland, Czechia, Germany, Hungary
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
The Fourth Affiliated Hospital of Zhejiang University...CompletedNSCLC | EGFR Gene Mutation | Non-small-lung-cell CancerChina
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Advaxis, Inc.Withdrawn
-
SCRI Development Innovations, LLCPfizerWithdrawnLung Cancer | Non-small Cell Lung CancerUnited States
-
Prelude TherapeuticsCompletedSarcoma | Non-small Cell Lung Cancer | Castrate Resistant Prostate Cancer | Solid Tumors With Known MYC Amplification | Hormone Receptor Positive HER2 Negative Breast CancerUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Novartis PharmaceuticalsCompletedNon-Small Cell Lung CancerUnited States, Spain, United Kingdom, Japan, Turkey, Belgium, Germany, Netherlands, Canada, Singapore, Switzerland, Israel, Russian Federation, Korea, Republic of, Hong Kong, Lebanon, Italy, France, Portugal, Ireland
-
TakedaCompletedCarcinoma Non-small-cell Lung | Anaplastic Lymphoma Kinase-positiveUnited States
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
TYK Medicines, IncCompleted
-
Sumitomo Pharma America, Inc.CompletedAdvanced Solid Tumors | Recurrent Ovarian Carcinoma | Colorectal Carcinoma | EGFR Positive Non-small Cell Lung Cancer | BRAF-Mutated MelanomaUnited States
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
Betta Pharmaceuticals Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer | EGFR Gene MutationChina
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
PfizerTerminatedALK or ROS1-positive NSCLCChina
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
JI-YOUN HANSeoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsActive, not recruitingNon Small Cell Lung CancerKorea, Republic of
-
Fate TherapeuticsTerminatedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumor | Small-cell Lung Cancer | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
Ariad PharmaceuticalsTakedaActive, not recruitingALK-positive Advanced NSCLCKorea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Fox Chase Cancer CenterWithdrawnNon-Small Cell Lung CancerUnited States
-
Instituto Nacional de Cancerologia de MexicoRoche Pharma AGCompletedALK Gene Rearrangement Positive | Non-Squamous Non-Small Cell Neoplasm of LungMexico
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Fate TherapeuticsCompletedMelanoma | Lymphoma | Renal Cell Carcinoma | Cervical Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | HER2-positive Breast Cancer | Pancreas Cancer | Urothelial Carcinoma | Merkel Cell Carcinoma | Microsatellite Instability and other conditionsUnited States
-
TakedaCompletedCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseArgentina
-
Qilu Pharmaceutical Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
PfizerCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Spanish Breast Cancer Research GroupBristol-Myers Squibb; Pfizer; Hoffmann-La RocheCompleted
-
University of California, San FranciscoNovartis Pharmaceuticals; University of California, DavisTerminatedNon-small Cell Lung CancerUnited States
-
Alpha Biopharma (Jiangsu) Co., Ltd.CompletedNon-small Cell Lung Cancer | Brain Metastases | EGFR Gene MutationChina, Korea, Republic of, Singapore, Taiwan
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungNetherlands
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
Xcovery Holding Company, LLCAvailableNon-Small Cell Lung Cancer | ALK Gene Rearrangement PositiveUnited States
-
Ludwig Institute for Cancer ResearchXcovery Holding Company, LLC; Cancer Research Institute, New York City; MedImmune...CompletedCarcinoma | NSCLC | Non-small Cell Lung CancerUnited States
-
European Organisation for Research and Treatment...AstraZenecaActive, not recruitingNSCLCFrance, Spain, Slovenia, Jordan, Poland